Patent: 8,252,933
✉ Email this page to a colleague
Summary for Patent: 8,252,933
| Title: | 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| Abstract: | The present invention relates to new 2-oxo-1,2-dihydro-quinoline modulators of immune function, pharmaceutical compositions thereof, and methods of use thereof. ##STR00001## |
| Inventor(s): | Gant; Thomas G. (Carlsbad, CA), Shahbaz; Manouchehr M. (Vista, CA) |
| Assignee: | Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) |
| Application Number: | 12/552,663 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,252,933
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Teknika Llc | N/A | bcg vaccine | For Injection | 103050 | 06/21/1989 | ⤷ Try a Trial | 2028-09-03 |
| Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2028-09-03 |
| Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 02/20/1991 | ⤷ Try a Trial | 2028-09-03 |
| Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 06/28/2000 | ⤷ Try a Trial | 2028-09-03 |
| Partner Therapeutics, Inc. | LEUKINE | sargramostim | For Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2028-09-03 |
| Partner Therapeutics, Inc. | LEUKINE | sargramostim | Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2028-09-03 |
| Centocor Ortho Biotech Products, L.p. | ORTHOCLONE OKT3 | muromanab-cd3 | Injection | 103463 | 09/14/1992 | ⤷ Try a Trial | 2028-09-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
